Market Closed -
Canadian Securities Exchange
15:13:39 15/04/2024 BST
|
5-day change
|
1st Jan Change
|
0.005
CAD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
11.02
|
2.521
|
0.3864
|
Enterprise Value (EV)
1 |
10.73
|
2.625
|
0.3844
|
P/E ratio
|
-0.79
x
|
-0.58
x
|
-0.43
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
EV / EBITDA
|
-5,109,198
x
|
-1,701,124
x
|
-
|
EV / FCF
|
-13,913,448
x
|
-3,260,277
x
|
2,735,787
x
|
FCF Yield
|
-0%
|
-0%
|
0%
|
Price to Book
|
9.1
x
|
13.4
x
|
-3.05
x
|
Nbr of stocks (in thousands)
|
31,492
|
50,423
|
77,290
|
Reference price
2 |
0.3500
|
0.0500
|
0.005000
|
Announcement Date
|
02/05/22
|
01/05/23
|
29/04/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-2.1
|
-1.543
|
-
|
EBIT
1 |
-0.1795
|
-2.137
|
-1.58
|
-0.3761
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.1729
|
-9.521
|
-3.579
|
-0.7657
|
Net income
1 |
-0.1729
|
-9.521
|
-3.579
|
-0.7657
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-0.4438
|
-0.0866
|
-0.0118
|
Free Cash Flow
|
-
|
-0.7712
|
-0.8051
|
0.1405
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/09/21
|
02/05/22
|
01/05/23
|
29/04/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
0.1
|
-
|
Net Cash position
1 |
0.32
|
0.29
|
-
|
0
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.0672
x
|
-
|
Free Cash Flow
|
-
|
-0.77
|
-0.81
|
0.14
|
ROE (net income / shareholders' equity)
|
-
|
-1,162%
|
-512%
|
-2,515%
|
ROA (Net income/ Total Assets)
|
-
|
-103%
|
-74.9%
|
-39.4%
|
Assets
1 |
-
|
9.245
|
4.781
|
1.944
|
Book Value Per Share
2 |
0.0100
|
0.0400
|
0
|
-0
|
Cash Flow per Share
2 |
0.0200
|
0.0100
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/09/21
|
02/05/22
|
01/05/23
|
29/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 464K | | +32.36% | 698B | | +26.51% | 568B | | -4.40% | 358B | | +19.46% | 328B | | +3.50% | 283B | | +16.34% | 238B | | +6.68% | 203B | | -9.08% | 198B | | +8.62% | 165B |
Other Pharmaceuticals
|